Abstract
Purpose
The prevalence of urothelial carcinoma is high in dialysis patients. Radical cystectomy is an invasive procedure for patients with recurrent, multiple, or invasive bladder cancer. However, the prognosis of radical cystectomy in dialysis patients has rarely been reported. This study investigates the long-term outcome of radical cystectomy in dialysis patients with bladder urothelial carcinoma.
Materials and methods
Clinical data of 193 dialysis patients with bladder urothelial carcinoma were reviewed. Among them, 45 patients received radical cystectomy. Thirty-two patients who received radical cystectomy with concurrent nephroureterectomy were in a stable chronic dialysis condition. In contrast, we performed radical cystectomy without concurrent nephroureterectomy for patients (N = 13) at high surgical risk, such as tumors combined with infection, or hemodynamically unstable. Survival was evaluated using the Kaplan–Meier method.
Results
The overall survival rates were 86.7, 80.0, 62.2, 44.4, and 35.6% at 3-months, 6-months, 1-year, 3-years, and 5-years, respectively. Patients who received concurrent nephroureterectomy had a higher mortality rate (13%) than radical cystectomy alone (0.0%) under operative 3 months. However, the patients who received concurrent nephroureterectomy had a higher 5-year survival rate than the group without concurrent nephroureterectomy (43.7 vs. 15.4%). The causes of death included dialysis complications (N = 19, 42.1%), infection (N = 7, 36.8%), and disease metastasis (N = 4, 21.1%).
Conclusion
Dialysis patients in a stable chronic dialysis condition with recurrent or invasive bladder urothelial carcinoma could have survival benefits in receiving concurrent nephroureterectomy.
Similar content being viewed by others
References
Maisonneuve P, Agodoa L, Gellert R, Stewart JH et al (1999) Cancer in patients on dialysis for end-stage renal disease. Lancet 354:93–99
Chang CH, Yang CM, Yang AH (2007) Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer 109:1487–1492
Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF (1993) The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 71:274–278
Chuang CH, Lee CT, Tsai TL, Chen JB et al (1999) Urological malignancy in chronic dialysis patients. Acta Nephrol Taiwan soc nephrol 16:19–24
Satoh S, Tsuchiya N, Habuchi T, Ishiyama T et al (2005) Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J Urol 174:1749–1753
Chen CY, Liao YM, Tsai WM, Kuo HC (2007) Upper urinary tract urothelial carcinoma in eastern Taiwan. J Formosan Med Assoc 106:992–998
Yang MH, Chen KK, Yen CC, Wang WS, Chang YH, Huang WJ, Fan FS, Chiou TJ, Liu JH, Chen PM (2002) Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59:681–687
Yang MH, Yen CC, Chen PM, Wang WS, Chang YH, Huang WJ, Fan FS, Chiou TJ, Liu JH, Chen KK (2002) Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan. Urology. 59:232–238; discussion 238–239
Stewart J, Buccianti G, Agogoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease : analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207
Chung SD, Huang KH, Lai MK, Huang CY et al (2007) CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Am J Kidney Dis 50:743–753
Hung YM, Chou KJ, Hung SY, Chung HM, Chang JC (2007) De novo malignancies after kidney transplantation. Urology 69:1041–1044
Jiaan BP, Yu CC, Lee YH, Huang JK (1993) Uraemia with concomitant urothelial cancer. Br J Urol 72:458–461
Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS (2004) Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J Urol 171:126–129
Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST (2006) The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176:477–481
Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, Chiang PH, Shiue YL (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98:1620–1626
Berglund RK, Matin SF, Desai M, Kaouk J, Gill IS (2006) Laparoscopic radical cystoprostatectomy with bilateral nephroureterectomy: initial report. BJU Int 97:37–41
Huang SC, Yang WC, Chen HS (2000) 1999 National dialysis surveillance in Taiwan. Acta Nephrol 14:139–228
Cuckovic C, Djukanovic L, Jankovic S et al (1996) Malignant tumors in hemodialysis patients. Nephron 73:710–712
Chen CH, Shun CT, Huang KH, Huang CY, Yu HJ, Pu YS (2008) Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease. Urology 71:1155–1160
Acknowledgments
The authors would like to thank Shu-Hui Yeh, RN, PhD from Chang Gung University College of Medicine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tseng, SF., Chuang, YC. & Yang, WC. Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma. Int Urol Nephrol 43, 1067–1071 (2011). https://doi.org/10.1007/s11255-011-9960-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-011-9960-7